首页> 外文期刊>Acta orthopaedica. >Good results in postoperative and hematogenous deep infections of 89 stable total hip and knee replacements with retention of prosthesis and local antibiotics
【24h】

Good results in postoperative and hematogenous deep infections of 89 stable total hip and knee replacements with retention of prosthesis and local antibiotics

机译:在保留假体和局部抗生素的情况下,对89例稳定的全髋关节和膝关节置换术进行术后和血源性深部感染的良好结果

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background Deep postoperative and hematogenous prosthesis infections may be treated with retention of the prosthesis, if the prosthesis is stable. How long the infection may be present to preclude a good result is unclear. Patients and methods We retrospectively studied 89 deep-infected stable prostheses from 69 total hip replacements and 20 total knee replacements. There were 83 early or delayed postoperative infections and 6 hematogenous. In the postoperative infections, treatment had started 12 days to 2 years after implantation. In the hematogenous infections, symptoms had been present for 6 to 9 days. The patients had been treated with debridement, prosthesis retention, systemic antibiotics, and local antibiotics: gentamicin-PMMA beads or gentamicin collagen fleeces. The minimum follow-up time was 1.5 years. We investigated how the result of the treatment had been influenced by the length of the period the infection was present, and by other variables such as host characteristics, infection stage, and type of bacteria. Results In postoperative infections, the risk of failure increased with a longer postoperative interval: from 0.2 (95% CI: 0.1-0.3) if the treatment had started ≥ 4 weeks postoperatively to 0.5 (CI: 0.2-0.8) if it had started at ≥ 8 weeks. The relative risk for success was 0.6 (CI: 0.3-0.95) if the treatment had started ≥ 8 weeks. In the hematogenous group, 5 of 6 infections had been treated successfully. Interpretation A longer delay before the start of the treatment caused an increased failure rate, but this must be weighed against the advantage of keeping the prosthesis. We consider a failure rate of < 50% to be acceptable, and we therefore advocate keeping the prosthesis for up to 8 weeks postoperatively, and in hematogenous infections with a short duration of symptoms.
机译:背景技术如果假体稳定,则深部的术后和血源性假体感染可以保留假体进行治疗。目前尚不清楚感染可能持续多长时间才能取得良好效果。患者和方法我们回顾性研究了69例全髋关节置换和20例全膝关节置换的89种深层感染稳定假体。术后发生早期或延迟感染83例,血源性6例。在术后感染中,植入后12天至2年开始治疗。在血源性感染中,症状已出现6至9天。患者接受了清创,假体保留,全身性抗生素和局部抗生素治疗:庆大霉素-PMMA珠或庆大霉素胶原蛋白羊毛。最小随访时间为1.5年。我们调查了治疗结果如何受到感染持续时间的长短以及诸如宿主特征,感染阶段和细菌类型等其他变量的影响。结果在术后感染中,失败的风险随着术后时间的延长而增加:如果在术后≥4周开始治疗,则失败的风险从0.2(95%CI:0.1-0.3)增加到在术后4周开始的0.5(CI:0.2-0.8)。 ≥8周。如果治疗开始≥8周,则成功的相对风险为0.6(CI:0.3-0.95)。在血源性组中,成功治疗了6例感染中的5例。解释在开始治疗之前较长的延迟会导致失败率增加,但这必须权衡保留假体的好处。我们认为小于50%的失败率是可以接受的,因此我们主张在手术后以及假体持续时间短的血源性感染中,将假体保持长达8周。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号